Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-01-18 1:30 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | JPMORGAN CHASE & CO JPM | 7,510,572 7.9% | 84,676 (+1.14%) | View |
| 2022-03-11 5:05 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | MAVERICK CAPITAL LTD | 7,855,824 8.4% | 531,285 (+7.25%) | View |
| 2022-02-14 6:58 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | Atara Biotherapeutics Inc. ATRA | 7,855,824 8.9% | 7,855,824 (New Position) | View |
| 2022-02-14 5:07 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | Redmile Group LLC | 9,098,725 9.9% | 1,235,112 (+15.71%) | View |
| 2022-02-14 4:28 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | Point72 Asset Management L.P. | 4,634,153 5.2% | 66,119 (+1.45%) | View |
| 2022-02-09 5:17 pm Sale | 13G | Atara Biotherapeutics Inc. ATRA | BAUPOST GROUP LLC | 8,123,616 9.19% | -985,372 (-10.82%) | View |
| 2022-02-09 3:24 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | VANGUARD GROUP INC | 7,075,521 8% | 1,437,247 (+25.49%) | View |
| 2022-02-09 09:09 am Purchase | 13G | Atara Biotherapeutics Inc. ATRA | FMR LLC | 5,613,242 6.348% | 3,155,500 (+128.39%) | View |
| 2022-02-03 4:41 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | BlackRock Inc. BLK | 7,816,552 8.8% | 1,362,137 (+21.10%) | View |
| 2022-01-07 3:41 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | JPMORGAN CHASE & CO JPM | 7,425,896 8.3% | 1,397,393 (+23.18%) | View |
| 2021-12-21 5:13 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | Point72 Asset Management L.P. | 4,568,034 5.2% | 4,568,034 (New Position) | View |
| 2021-02-16 4:23 pm Sale | 13G | Atara Biotherapeutics Inc. ATRA | BRIDGER MANAGEMENT LLC | 1,524,760 1.8% | -1,408,105 (-48.01%) | View |
| 2021-02-16 4:09 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | Redmile Group LLC | 7,863,613 9.9% | 2,369,504 (+43.13%) | View |
| 2021-02-16 1:41 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | MAVERICK CAPITAL LTD | 7,324,539 8.9% | 2,366,108 (+47.72%) | View |
| 2021-02-16 08:19 am Sale | 13G | Atara Biotherapeutics Inc. ATRA | Camber Capital Management LP | 0 0% | -2,950,000 (Position Closed) | View |
| 2021-02-12 3:12 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | BAUPOST GROUP LLC | 9,108,988 11.07% | 800,088 (+9.63%) | View |
| 2021-02-10 10:30 am Purchase | 13G | Atara Biotherapeutics Inc. ATRA | VANGUARD GROUP INC | 5,638,274 6.85% | 1,956,573 (+53.14%) | View |
| 2021-01-28 5:56 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | BlackRock Inc. BLK | 6,454,415 7.8% | 1,874,001 (+40.91%) | View |
| 2021-01-08 11:43 am Purchase | 13G | Atara Biotherapeutics Inc. ATRA | JPMORGAN CHASE & CO JPM | 6,028,503 7.3% | 6,028,503 (New Position) | View |
| 2020-02-14 4:26 pm Purchase | 13G | Atara Biotherapeutics Inc. ATRA | Redmile Group LLC | 5,494,109 9.9% | 1,079,492 (+24.45%) | View |